Samsung Biologics Co. on Wednesday reported its second-quarter net income of 318 billion won (US$229.8 million), up 72 percent from a year earlier. The company said in a regulatory filing that operating income for the April-June period rose 71.4 percent on-year to 434.5 billion won. Revenue increased 33.6 percent to 1.15 trillion won. The operating profit was 46.0 percent higher than the average estimate, according to a survey by Yonhap Infomax, the financial data firm of Yonhap News Agency. The estimate of net profit was not available. Source: Yonhap News Agency
Samsung Biologics Q2 net income up 72 pct to 318 bln won
Recent News
Taichung MRT Cars from Fatal 2023 Crash to Be Auctioned Off
November 19, 2026
Study Links Obesity and Fried Foods to Accelerated Biological Aging
November 19, 2026
MOENV Repair Vouchers Claimed Rapidly After Release
November 19, 2026
MOENV’s Repair Voucher Program Sees Rapid Uptake in Taiwan
November 19, 2026
MOENV’s Repair Vouchers Quickly Claimed in Tainan and Taoyuan
November 19, 2026
Taichung MRT Cars from 2023 Crane Accident Set for Auction
November 19, 2026